Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER

Bayer hires law firm to probe Monsanto data collection

Stock Markets May 21, 2019 08:05AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Headquarters and main plant of German pharmaceutical and chemical maker Bayer AG in Leverkusen
 
BAYGN
-0.35%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MON
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

BERLIN (Reuters) - Bayer (DE:BAYGN) on Tuesday hired law firm Sidley Austin to investigate a Europe-wide data collection scheme run by its Monsanto (NYSE:MON) unit, which targeted journalists, politicians and other stakeholders to influence the debate on pesticides.

Bayer last week admitted that Monsanto, which it acquired for $63 billion last year, had gathered non-public information as part of the campaign, which French media said sought to influence the public debate on pesticides and genetically modified products.

Bayer faces potentially heavy litigation costs from U.S. class-action lawsuits in which plaintiffs claim that its Roundup weedkiller, which contains glyphosate, causes cancer. Bayer disputes this.

In a Q&A document posted on its website on Tuesday, Bayer said U.S public relations and marketing agency FleishmanHillard, on behalf of Monsanto, had mapped stakeholders in France, Germany, Italy, Netherlands, Poland, Spain, and United Kingdom as well as stakeholders related to EU institutions.

Sidley Austin will investigate how many stakeholders were included in those files and whether people from other countries could also be affected, Bayer said.

The law firm would then contact affected people, most of them journalists, politicians and scientists, no later than by the end of the coming week.

French prosecutors said they had opened an inquiry after newspaper Le Monde filed a complaint alleging that Monsanto had kept a file of 200 names in hopes of influencing their positions.

Bayer has ended its PR collaboration with FleishmanHillard, but continues to work with the firm on marketing projects.

Bayer shares have shed more than 40 percent since a first adverse U.S. judgment on Roundup last August, leaving the company with a market capitalization smaller than the price it paid for Monsanto.

Bayer hires law firm to probe Monsanto data collection
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email